Latest News

Viridian Therapeutics (VRDN) is back on investors' radar after a rise in institutional ownership and strong year over year gains in quarterly revenue and net profit, which has drawn fresh attention to the stock. See our latest analysis for Viridian Therapeutics. At a share price of $16.63, Viridian Therapeutics has seen its 7 day and 30 day share price returns of 3.04% and 4.13% contrast with a much weaker 90 day share price return, while a 1 year total shareholder return of 10.87% sits...

Crinetics Pharmaceuticals (CRNX) is back in focus after presenting extensive new data at the Endocrine Society’s 2026 meeting, covering both its approved acromegaly drug PALSONIFY and its investigational ACTH receptor antagonist atumelnant. See our latest analysis for Crinetics Pharmaceuticals. Crinetics Pharmaceuticals’ recent ENDO 2026 updates have arrived alongside a mixed share price picture, with a 7 day share price return of 6.98% contrasting with a year to date decline of 23.24%, while...

Benchmark Electronics (BHE) is back in focus after expanding its manufacturing partnership with Ouster for Rev8 lidar sensors and receiving Hewlett Packard Enterprise’s 2026 Manufacturing Partner of the Year award for work on advanced AI infrastructure. See our latest analysis for Benchmark Electronics. Benchmark Electronics’ recent lidar and AI manufacturing wins come on top of strong market interest, with a 30-day share price return of 13.36% and a year-to-date share price return of...

Teleflex stock reaction centered on earnings, not new debt issue Teleflex (TFX) has been drawing attention after Q1 revenue topped analyst expectations and investors responded positively, even as the company issued new senior notes and reiterated full year EPS guidance below prior estimates. The recent share price move appears more closely linked to Teleflex's earnings update, where revenue performance and progress on its transformation plan supported sentiment, rather than to the sizeable...

In mid-June 2026, Japan’s Fair Trade Commission raided Morinaga Milk Industry and five other ice cream makers over suspected long-running price fixing, with all firms pledging to cooperate with the antitrust probe. The investigation, described locally as a potential price cartel involving senior executives, raises significant questions about Morinaga’s pricing practices, governance culture, and future regulatory scrutiny. We’ll now examine how the alleged price-fixing probe, and the scrutiny...

With inflation signals, energy prices and central bank policies all pulling markets in different directions, many investors are looking for income streams that feel more dependable than short term sentiment. That is where Dividend Fortresses comes in, a screener focused on stocks offering 5%+ dividend yields with an emphasis on resilience. Instead of chasing the latest theme, you focus on cash in hand while still staying invested across market cycles. In this article, you will see three...

Earlier this month, SLB launched the SLB Digital Marketplace, a curated platform offering around 200 certified AI agents, domain models, tools, data connectors and digital applications for energy companies’ existing Delfi, Lumi and Tela environments. This move deepens SLB’s push into higher-margin digital and AI workflows, aiming to turn its platforms into an ecosystem where customers and third‑party developers can build, distribute and integrate specialized energy solutions through a single...

Why Qfin Holdings' latest quarter matters for investors Qfin Holdings (QFIN) has just reported a mixed quarter that turned attention to its changing user mix, tighter risk controls, and outlook for non-GAAP earnings in a tougher retail credit market. The company highlighted improvements in risk indicators and operational efficiency, but also flagged ongoing macro uncertainty and rising regulatory pressure, guiding investors to expect a sizeable year-on-year decline in non-GAAP net income for...

BrightView Holdings (BV) has just pushed out the maturity of its senior secured term loans to June 2033 and extended its receivables financing facility to 2029, a financing move that helps explain the recent stock reaction. See our latest analysis for BrightView Holdings. For context, BrightView Holdings’ recent financing moves arrive after a period where share price momentum has picked up in the short term, with a 1 month share price return of 8.75% and a 3 month share price return of...

Recently, Essential Utilities Inc. reported an earnings forecast score of 6.57, ranking 9th out of 14 in the Water & Related Utilities industry, alongside analyst ratings that lean toward a hold signal with an average price target of US$43.00. At the same time, institutional ownership climbed to 81.57% of shares, with the largest holder, ETHSX, increasing its stake by a very large percentage, hinting at strengthening institutional confidence in the company. Next, we’ll examine how this...

Xometry (XMTR) is drawing fresh attention after rolling out new injection molding features that focus on accuracy, design feedback, and faster ordering. This raises questions about what this means for the stock’s long term story. See our latest analysis for Xometry. The product updates arrive after a sharp run in Xometry’s stock, with a 90 day share price return of 137.96% and a 1 year total shareholder return of 187.46%, suggesting momentum has been strong alongside other recent funding and...

Siegfried Holding (SWX:SFZN) has opened a new large scale API manufacturing facility in Minden, Germany, adding 100 m³ of reactor capacity and expanding its role as a global CDMO for small molecule drug substances. See our latest analysis for Siegfried Holding. Despite Siegfried Holding’s new API facility pointing to expanded capacity and customer demand, recent momentum has been weak, with the share price down 16.82% over 30 days and the 1 year total shareholder return down 28.36%,...

Earlier this month, Vaxcyte announced that it has dosed the first participant in its Phase 1, first-in-human trial of VAX-A1, an investigational vaccine targeting Group A Streptococcus, with topline safety and tolerability data expected in the second half of 2027. This milestone advances Vaxcyte’s pipeline into human testing for a pathogen that currently has no approved vaccine, highlighting the company’s effort to address a significant infectious disease burden. We’ll now examine how...

Cullen/Frost Bankers recently reported past quarterly results showing revenue of US$538.44M and net profit both rising year over year, alongside stable finances but relatively low operating efficiency. At the same time, institutional ownership climbed to 92.83% with the top holder modestly increasing its stake, highlighting strong interest from large professional investors. We’ll now examine how this combination of solid financial performance and rising institutional ownership could...

Universal Insurance Holdings (UVE) has just completed a US$100 million private placement of 7.75% Senior Unsecured Notes due 2031, a move tied to redeeming its existing 5.625% Senior Notes maturing in 2026. See our latest analysis for Universal Insurance Holdings. Set against this new US$100 million note issuance, Universal Insurance Holdings’ share price has climbed 15.0% over the past 90 days and its 1 year total shareholder return is 49.06%, indicating sustained positive momentum rather...

Fiverr International (FVRR) is drawing fresh attention after analysts flagged expectations for year over year declines in both earnings and revenue ahead of upcoming results, along with a less favorable industry ranking. See our latest analysis for Fiverr International. The recent 1 day share price return of 7.90% to US$10.38 comes after a weak stretch, with the year to date share price return down 47.26% and the 1 year total shareholder return down 64.96%. This suggests sentiment around...

Earlier in 2026, PulteGroup’s Del Webb brand broke ground on a future resort-style clubhouse at Del Webb Desert Retreat in Indio, California, while the homebuilder reported a mixed first quarter with revenue in line, a small adjusted operating income beat, and an earnings-per-share miss. Together with commentary on soft revenue trends, lower earnings per share, and weaker returns on capital, these updates highlight how PulteGroup is investing in higher-margin active-adult communities even...

Recently, reports showed that GEO Group asked US Immigration and Customs Enforcement (ICE) to alter federal detention standards, including the removal of certain detainee-treatment language, and ICE’s newly published rules appear to incorporate several of those requested changes. This alignment between a major ICE contractor’s requests and revised government standards raises fresh questions about how policy shifts may influence GEO’s operating risks and legal exposure. Next, we’ll examine...

Martin Marietta Materials recently reported a record first quarter of 2026, with revenue up 17% and adjusted EBITDA rising 14%, reaffirming full-year guidance and highlighting strong aggregates and infrastructure demand. The company also underscored its ongoing portfolio reshaping through the QUIKRETE asset exchange and New Frontier Materials acquisition, sharpening its focus on higher-quality aggregates markets and earnings durability. Next, we’ll examine how the reaffirmed 2026 guidance...

RemeGen (SEHK:9995) is back in focus after China’s National Medical Products Administration approved new indications for its autoimmune drug Telitacicept in Sjögren’s disease and conditionally in IgA nephropathy, expanding its treated patient pools. See our latest analysis for RemeGen. At a latest share price of HK$68.5, RemeGen’s 1 day share price return of 1.63% follows a 30 day share price decline of 19.32%. Its 1 year total shareholder return of 37.27% and 3 year total shareholder return...

Astrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP related offering, shortly after reporting operating efficiency and financial metrics that highlight its current business momentum. See our latest analysis for Astrana Health. The latest shelf registration comes at a time when Astrana Health’s share price has gained 61.66% over the past 90 days and its 1 year...

LXP Industrial Trust (LXP) has drawn fresh attention after its recent share price move, with the stock showing gains over the month and the past 3 months. Investors are reassessing the REIT’s warehouse focused portfolio. See our latest analysis for LXP Industrial Trust. At a latest share price of $53.18, LXP Industrial Trust has built momentum, with a 30 day share price return of 3.30% and a 90 day share price return of 14.22%, while the 1 year total shareholder return of 30.01% points to a...

Cochlear (ASX:COH) is back in focus after the company issued a 2026 guidance downgrade, prompting a reset in expectations for both the stock and the broader premium ASX healthcare segment. See our latest analysis for Cochlear. The 2026 guidance downgrade comes after a sharp rebound in Cochlear’s share price over the past month, with a 30 day share price return of 24.66%. However, that short term strength contrasts with a much weaker backdrop, including a 90 day share price decline of 28.23%...

Fervo Energy recently promoted Sarah Jewett to Chief Operating Officer, placing her in charge of core corporate operations as the company builds centralized infrastructure to pursue what it views as a major commercial opportunity in clean, firm power. Jewett’s combination of hands-on hydraulic fracturing field experience and corporate strategy leadership gives Fervo an operations chief who can connect complex technical execution with high-level decision-making. With Jewett’s expanded...